ArticleScientific reports2019

Clinical implications of drug-screening assay for recurrent metastatic hormone receptor-positive, human epidermal receptor 2-negative breast cancer using conditionally reprogrammed cells.

Rei Mimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.